Skip to content
HowShorted

HEALTHCARE SERVICES GROUP INC short interest in 2023

In 2023, HEALTHCARE SERVICES GROUP INC's disclosed short interest ran from 5.04% of shares outstanding on 13 Jan 2023 to 3.71% on 29 Dec 2023, a change of -1.33 percentage points. The year's high was 7.25% on 15 Mar 2023 and its low 2.87% on 15 Aug 2023, averaging 4.94% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 9.38 days on 13 Jan 2023. Full history: HEALTHCARE SERVICES GROUP INC.

Cite this page
Plain
Wikipedia
BibTeX

By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026

Aggregate net short position time series for HEALTHCARE SERVICES GROUP INC in 2023

2023 in figures

Start of year
5.04% (13 Jan 2023)
End of year
3.71% (29 Dec 2023)
Change
-1.33 pp
High
7.25% (15 Mar 2023)
Low
2.87% (15 Aug 2023)
Average
4.94%
Highest days to cover
9.38 (13 Jan 2023)
SEC filings marked
8

Every report in 2023

HEALTHCARE SERVICES GROUP INC short interest in 2023
SettlementShort interestDays to coverFilings since previous
13 Jan 20235.04%9.38
31 Jan 20235.27%5.22
15 Feb 20235.62%6.87results (8-K)
28 Feb 20236.89%3.3310-K filed
15 Mar 20237.25%5.09
31 Mar 20237.06%3.72
14 Apr 20236.92%5.22
28 Apr 20236.63%5.12results (8-K), 10-Q filed
15 May 20236.01%7.15
31 May 20236.09%7.13
15 Jun 20236.36%7.02
30 Jun 20235.64%5.71
14 Jul 20235.38%4.90
31 Jul 20233.27%1.89results (8-K), 10-Q filed
15 Aug 20232.87%4.14
31 Aug 20232.98%5.61
15 Sep 20233.16%2.55
29 Sep 20233.34%3.01
13 Oct 20233.70%3.94
31 Oct 20233.33%2.03results (8-K), 10-Q filed
15 Nov 20233.88%4.23
30 Nov 20233.97%5.47
15 Dec 20234.17%3.73
29 Dec 20233.71%5.79

See also: HEALTHCARE SERVICES GROUP INC's full history · most shorted US stocks of 2023 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.